Introduction
A proportion of patients with aortic aneurysms (AA) do not proceed to intervention after reaching treatment threshold diameter due to a combination of poor cardiovascular reserve, frailty and aortic morphology. This patient cohort has a high mortality, however, there exist no studies on the palliative care (PC) and advance care planning (ACP) they receive following discharge from the clinic.
Methods
We conducted a multicentre cohort study of 220 conservatively managed AA patients referred to centres in Leeds and the Maastricht for intervention between 2017 and 2021, from a combined total of 1506 patients - a non-intervention rate of 15%. Demographic details, mortality, cause of death, ACP and PC outcomes were analysed to examine predictors of PC referral and consultation efficacy.
Results
There was a 3-year mortality rate of 60%. Rupture was the reported cause of death in 17% of the decedents. Only 9% of all patients received PC referrals - a median of 3.5 days before death. Patients over 80 were more likely to have PCCs. Almost half of the decedents were readmitted to hospital before death and 37% died in hospital. Only 5% of patients had a documented preferred place of death. Patients with PCCs were more likely to have preferred place of death and care priorities documented.
Conclusion
Only a small proportion of conservatively treated patients with AAs had ACP, far below 2019 NICE end-of-life care guidance. It is also far below the level offered to oncology patients. Pathways and guidance should be implemented to ensure patients not offered AA intervention are offered end-of-life care and ACP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.